DE69838662D1 - Morphinanderivate und ihre medizinische Anwendung - Google Patents

Morphinanderivate und ihre medizinische Anwendung

Info

Publication number
DE69838662D1
DE69838662D1 DE69838662T DE69838662T DE69838662D1 DE 69838662 D1 DE69838662 D1 DE 69838662D1 DE 69838662 T DE69838662 T DE 69838662T DE 69838662 T DE69838662 T DE 69838662T DE 69838662 D1 DE69838662 D1 DE 69838662D1
Authority
DE
Germany
Prior art keywords
medical use
morphine derivatives
morphinan derivatives
opioid
epsilon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69838662T
Other languages
English (en)
Other versions
DE69838662T2 (de
Inventor
Hiroshi Nagase
Hideaki Fujii
Takashi Endoh
Koji Kawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of DE69838662D1 publication Critical patent/DE69838662D1/de
Application granted granted Critical
Publication of DE69838662T2 publication Critical patent/DE69838662T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Emergency Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69838662T 1997-03-27 1998-03-27 Morphinanderivate und ihre medizinische Anwendung Expired - Fee Related DE69838662T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7634097 1997-03-27
JP7634097 1997-03-27
PCT/JP1998/001376 WO1998043978A1 (fr) 1997-03-27 1998-03-27 Derives de morphinane et usage medical de ces derniers

Publications (2)

Publication Number Publication Date
DE69838662D1 true DE69838662D1 (de) 2007-12-20
DE69838662T2 DE69838662T2 (de) 2008-08-28

Family

ID=13602637

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69838662T Expired - Fee Related DE69838662T2 (de) 1997-03-27 1998-03-27 Morphinanderivate und ihre medizinische Anwendung

Country Status (12)

Country Link
US (1) US6187782B1 (de)
EP (1) EP0915094B1 (de)
KR (1) KR20000016052A (de)
CN (1) CN1150196C (de)
AT (1) ATE377602T1 (de)
AU (1) AU743929B2 (de)
CA (1) CA2256897C (de)
DE (1) DE69838662T2 (de)
ES (1) ES2297882T3 (de)
NO (1) NO985518L (de)
NZ (1) NZ333101A (de)
WO (1) WO1998043978A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2308990T3 (es) * 1999-08-24 2008-12-16 Toray Industries, Inc. Remedios para el dolor neuropatico y modelos animales de dolor neuropatico.
CA2674915C (en) * 2006-10-17 2015-06-30 Penick Corporation Process for preparing oxymorphone
US20080125592A1 (en) 2006-10-17 2008-05-29 Penick Corporation Process for preparing oxymorphone, naltrexone, and buprenorphine
EP2073636B1 (de) 2006-10-17 2012-09-05 Penick Corporation Verfahren für die herstellung von oxymorphon
AU2012216358B2 (en) * 2006-10-17 2014-11-20 Penick Corporation Process For Preparing Oxymorphone, Naltrexone and Buprenorphine
PL2522667T3 (pl) 2007-05-01 2015-01-30 Concert Pharmaceuticals Inc Związki morfinanu
CA3208128A1 (en) 2007-05-01 2008-11-13 Sun Pharmaceutical Industries, Inc. Morphinan compounds
JP5252391B2 (ja) * 2008-02-21 2013-07-31 学校法人北里研究所 オキサビシクロ［２．２．２］オクタンを有するモルヒナン誘導体およびその医薬用途
US8686158B2 (en) 2008-06-05 2014-04-01 President And Fellows Of Harvard College High-valent palladium fluoride complexes and uses thereof
KR101682963B1 (ko) * 2008-10-24 2016-12-06 도레이 카부시키가이샤 4,5-에폭시모르피난 유도체를 함유하는 안정한 정제
KR20110095898A (ko) 2008-11-20 2011-08-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 유기 화합물의 플루오르화
KR20110104097A (ko) * 2009-01-09 2011-09-21 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 불소 함유 화합물 및 이의 사용방법
JP2014073964A (ja) * 2011-01-28 2014-04-24 Kitasato Institute モルヒナン誘導体
US9150516B2 (en) 2011-04-12 2015-10-06 President And Fellows Of Harvard College Fluorination of organic compounds
JP6061857B2 (ja) 2011-09-09 2017-01-18 学校法人北里研究所 モルヒナン誘導体
WO2014021273A1 (ja) * 2012-07-30 2014-02-06 学校法人北里研究所 モルヒナン誘導体
WO2014052622A1 (en) 2012-09-26 2014-04-03 President And Fellows Of Harvard College Nickel fluorinating complexes and uses thereof
JP6181770B2 (ja) 2012-12-31 2017-08-16 ローズ テクノロジーズ ７β−置換６α，１４α−エテノモルフィナンおよび７β−置換６α，１４α−エタノモルフィナンを調製するための方法
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
WO2015058047A2 (en) 2013-10-18 2015-04-23 President And Fellows Of Harvard College Fluorination of organic compounds
JP6814470B2 (ja) * 2017-02-10 2021-01-20 国立大学法人 筑波大学 モルヒナン誘導体
WO2019045006A1 (ja) * 2017-08-31 2019-03-07 日本ケミファ株式会社 モルヒナン誘導体
WO2019168025A1 (ja) * 2018-02-28 2019-09-06 日本ケミファ株式会社 モルヒナン誘導体の製造方法
JP2021104932A (ja) * 2018-03-30 2021-07-26 日本ケミファ株式会社 モルヒナン誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229770A1 (de) 1972-06-19 1974-01-10 Boehringer Sohn Ingelheim N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung
ZA855058B (en) 1984-07-05 1987-03-25 Du Pont Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans,intermediates thereto,and processes
PT95069B (pt) 1989-08-24 1997-10-31 Searle & Co Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
ES2121988T3 (es) * 1992-01-23 1998-12-16 Toray Industries Derivado de morfinano y uso medicinal.

Also Published As

Publication number Publication date
EP0915094B1 (de) 2007-11-07
NO985518L (no) 1999-01-21
ES2297882T3 (es) 2008-05-01
AU743929B2 (en) 2002-02-07
AU6518998A (en) 1998-10-22
EP0915094A4 (de) 2004-09-22
EP0915094A1 (de) 1999-05-12
WO1998043978A1 (fr) 1998-10-08
NZ333101A (en) 2000-05-26
CA2256897A1 (en) 1998-10-08
CN1150196C (zh) 2004-05-19
DE69838662T2 (de) 2008-08-28
CA2256897C (en) 2006-10-03
KR20000016052A (ko) 2000-03-25
ATE377602T1 (de) 2007-11-15
CN1220667A (zh) 1999-06-23
US6187782B1 (en) 2001-02-13
NO985518D0 (no) 1998-11-26

Similar Documents

Publication Publication Date Title
DE69838662D1 (de) Morphinanderivate und ihre medizinische Anwendung
ATE212978T1 (de) Para-substituierte phenylpropansäure derivate als integrin-antagonisten
DE60140456D1 (de) Aza heterocyclische derivate und ihre therapeutische verwendung
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
BG66085B1 (bg) Фенилаланинови производни
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
EA200200716A1 (ru) Арилконденсированные азаполициклические соединения
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
ATE350036T1 (de) Tetrahydroquinolin-derivate
EA200300528A1 (ru) 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6
ATE414516T1 (de) Morphinanderivate als mittel gegen juckreiz
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
MXPA04000278A (es) Uso de antagonistas del receptor nk-1 con estructura piridinica para tratamiento de lesiones cerebrales, espinales o neuronales.
EA200400467A1 (ru) Производные 3-азабицикло (3.1.0) гексана в качестве антагонистов опиоидного рецептора
MXPA05013474A (es) Derivados de quinolilamida como antagonistas de ccr-5.
EA200300716A1 (ru) Гетероциклилалкилиндольные или -азаиндольные соединения в качестве лиганд 5-гидрокситриптамина-6
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
DE60121461D1 (de) Kondensierte pyridoindolderivate
ATE318266T1 (de) 3-substituierte chinolin-4- carbonsäureamidderivate als nk-3- und nk-2- rezeptorantagonisten
DK1336407T3 (da) Præparat indeholdende en angiotensin-II-receptorantagonist og et diuretikum og anvendelse deraf til behandling af hypertension
EA200301203A1 (ru) Новые соединения и композиции как ингибиторы катепсина
CA2356985A1 (en) 5ht1 antagonists for antidepressant therapy
WO2001010860A3 (en) Quinazolinone and azaquinazolinone derivatives
DE60326933D1 (de) Kondensierte bicyclische pyrimidinderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee